Research and Markets has announced the addition of the "Contraceptives Market - Forecast (2016-2022)" report to their offering.

Contraception can be defined as the deliberate prevention of pregnancy by interfering with the normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques and the devices used for contraception are called as contraceptives. Contraceptives drugs or devices not only inhibit pregnancy, but also sexually transmitted diseases (STDs). Globally, increasing awareness about STD and population control measures are expected to be the key growth drivers for the contraceptives market during the period of study.

Geographically, North America dominated the contraceptives market driven by higher demand and consumption of contraceptives due to higher awareness about its benefits and population control in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for the contraceptives market.

Asia Pacific is projected to have the fastest growth, owing to rapidly growing awareness amongst people in the region about contraceptives and initiatives by governments in developing nations such as China and India to educate people to control population in two most populated nations in the world.

Companies Mentioned:

  • Cooper Surgical, Inc.
  • Bayer AG
  • Actavis, Inc.
  • The Female Health Company
  • Merck & Co., Inc.
  • Mayer Laboratories, Inc.
  • Pfizer, Inc.
  • Church & Dwight, Co., Inc.
  • Medisafe Distribution Inc.
  • Teva Pharmaceutical Industries Limited

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Contraceptives Market, By Product

7. Contraceptives Market, By End-User

8. Contraceptives Market, By Geography

9. Market Entropy

10. Company Profiles

11. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/648g6x/contraceptives